DIAGNOS (ADK) Stock Overview
Provides software-based services for healthcare sector in Canada, the United States, Mexico, Chile, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
ADK Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
DIAGNOS Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.31 |
| 52 Week High | CA$0.42 |
| 52 Week Low | CA$0.18 |
| Beta | -0.23 |
| 1 Month Change | -13.89% |
| 3 Month Change | 24.00% |
| 1 Year Change | 21.57% |
| 3 Year Change | 72.22% |
| 5 Year Change | -46.55% |
| Change since IPO | -99.40% |
Recent News & Updates
Recent updates
Shareholder Returns
| ADK | CA Healthcare Services | CA Market | |
|---|---|---|---|
| 7D | 6.9% | -8.3% | -1.2% |
| 1Y | 21.6% | 13.6% | 18.2% |
Return vs Industry: ADK exceeded the Canadian Healthcare Services industry which returned 13.6% over the past year.
Return vs Market: ADK exceeded the Canadian Market which returned 18.2% over the past year.
Price Volatility
| ADK volatility | |
|---|---|
| ADK Average Weekly Movement | 9.7% |
| Healthcare Services Industry Average Movement | 9.2% |
| Market Average Movement | 10.1% |
| 10% most volatile stocks in CA Market | 19.5% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: ADK has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: ADK's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | n/a | Andre Larente | www.diagnos.com |
DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, Chile, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialist to visualize normal retinal landmarks and pathological changes. The company also provides various consulting services in the fields of data analysis and artificial intelligence.
DIAGNOS Inc. Fundamentals Summary
| ADK fundamental statistics | |
|---|---|
| Market cap | CA$30.90m |
| Earnings (TTM) | -CA$4.68m |
| Revenue (TTM) | CA$86.51k |
Is ADK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ADK income statement (TTM) | |
|---|---|
| Revenue | CA$86.51k |
| Cost of Revenue | CA$1.31m |
| Gross Profit | -CA$1.23m |
| Other Expenses | CA$3.46m |
| Earnings | -CA$4.68m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.045 |
| Gross Margin | -1,418.21% |
| Net Profit Margin | -5,413.40% |
| Debt/Equity Ratio | -293.2% |
How did ADK perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/19 00:32 |
| End of Day Share Price | 2025/11/19 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
DIAGNOS Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Stefan Quenneville | Ventum Financial Corp |